Home

hugleiðsla Smári fylgja með nmd pharma aps Fræðilegt Áhorfandi hvítt

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma - Crunchbase Company Profile & Funding

WO2016202341A1 - Compounds for use in treating neuromuscular disorders -  Google Patents
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents

Ulrik Sørensen – CEO – Ankrin Therapeutics | LinkedIn
Ulrik Sørensen – CEO – Ankrin Therapeutics | LinkedIn

NMD Pharma
NMD Pharma

Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review

DKBIO2019 « DK Bio Access
DKBIO2019 « DK Bio Access

News — NMD Pharma
News — NMD Pharma

Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email

Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review

NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark

HITTA ER ET A UN AMI TA ON HI HA UT ME AT THE
HITTA ER ET A UN AMI TA ON HI HA UT ME AT THE

Lars J. S. Knutsen - VP, Medicinal Chemistry - NMD Pharma ApS | LinkedIn
Lars J. S. Knutsen - VP, Medicinal Chemistry - NMD Pharma ApS | LinkedIn

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

NMD Pharma A/S | Virksomhedsprofil og regnskaber | eStatistik
NMD Pharma A/S | Virksomhedsprofil og regnskaber | eStatistik

Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review

NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout  Access
NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout Access

About - InsuSense Therapeutics
About - InsuSense Therapeutics

WO2016202341A1 - Compounds for use in treating neuromuscular disorders -  Google Patents
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents

Management team — NMD Pharma
Management team — NMD Pharma

Claus Oleson - BioLeader Interview - PIR International
Claus Oleson - BioLeader Interview - PIR International

NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark

NMD Pharma
NMD Pharma

NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout  Access
NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout Access

Our Business | Aristo Nordic ApS
Our Business | Aristo Nordic ApS

NMD Pharma
NMD Pharma